Title of article
Intravitreal Injection of Bevacizumab (Avastin) to Treat Posterior Capsule Neovascularization
Author/Authors
Manaviat، Masoud Reza نويسنده Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , , Chiti، Zohreh نويسنده Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran ,
Issue Information
فصلنامه با شماره پیاپی 0 سال 2010
Pages
3
From page
32
To page
34
Abstract
We report a 64-year-old diabetic woman who developed neovascularization of the posterior capsule 2 years after cataract surgery and intraocular lens implantation. The patient was treated with single injection of 1.25 mg of intravitreal bevacizumab (Avastin) via pars plana. After one week, complete regression of the posterior capsule neovascularization was achieved allowing us to perform Nd: YAG capsulotomy without serious complications. Intravitreal injection of bevacizumab can successfully regress the posterior capsule neovascularization resulting in improving patientʹs visual acuity.
Journal title
Iranian Journal of Diabetes and Obesity
Serial Year
2010
Journal title
Iranian Journal of Diabetes and Obesity
Record number
655715
Link To Document